Fenofibrate differentially regulates plasminogen activator inhibitor-1 gene expression via adenosine monophosphate-activated protein kinase-dependent induction of orphan nuclear receptor small heterodimer partner
about
Transcriptional corepressor SHP recruits SIRT1 histone deacetylase to inhibit LRH-1 transactivationSmall Heterodimer Partner and Innate Immune RegulationSmall heterodimer partner-targeting therapy inhibits systemic inflammatory responses through mitochondrial uncoupling protein 2Role of nuclear receptor SHP in metabolism and cancer.AMPK-Dependent Metabolic Regulation by PPAR Agonists.AMPK-dependent repression of hepatic gluconeogenesis via disruption of CREB.CRTC2 complex by orphan nuclear receptor small heterodimer partner.Involvement of SIK3 in glucose and lipid homeostasis in mice.Bile acid signaling in lipid metabolism: metabolomic and lipidomic analysis of lipid and bile acid markers linked to anti-obesity and anti-diabetes in mice.Aliskiren attenuates steatohepatitis and increases turnover of hepatic fat in mice fed with a methionine and choline deficient diet.Cannabinoid receptor type 1 (CB1R) signaling regulates hepatic gluconeogenesis via induction of endoplasmic reticulum-bound transcription factor cAMP-responsive element-binding protein H (CREBH) in primary hepatocytesFenofibrate inhibited the differentiation of T helper 17 cells in vitro.Phthalate exposure changes the metabolic profile of cardiac muscle cells.Metformin inhibits growth hormone-mediated hepatic PDK4 gene expression through induction of orphan nuclear receptor small heterodimer partner.Female mice are more susceptible to nonalcoholic fatty liver disease: sex-specific regulation of the hepatic AMP-activated protein kinase-plasminogen activator inhibitor 1 cascade, but not the hepatic endotoxin response.Decoding the role of the nuclear receptor SHP in regulating hepatic stellate cells and liver fibrogenesis.Targeting orphan nuclear receptor SHP in the treatment of metabolic diseases.PAI-1 in tissue fibrosis.Adipocytokines and hepatic fibrosis.Small heterodimer partner attenuates profibrogenic features of hepatitis C virus-infected cells.Selective peroxisome proliferator-activated receptor-α modulator K-877 efficiently activates the peroxisome proliferator-activated receptor-α pathway and improves lipid metabolism in mice.Compound K modulates fatty acid-induced lipid droplet formation and expression of proteins involved in lipid metabolism in hepatocytes.Small heterodimer partner SHP mediates liver X receptor (LXR)-dependent suppression of inflammatory signaling by promoting LXR SUMOylation specifically in astrocytes.AMPK: a novel target for treating hepatic fibrosisIn situ labeling and magnetic resonance imaging of transplanted human hepatic stem cells.Quercetin ameliorates dysregulation of lipid metabolism genes via the PI3K/AKT pathway in a diet-induced mouse model of nonalcoholic fatty liver disease.Delayed treatment with fenofibrate protects against high-fat diet-induced kidney injury in mice: the possible role of AMPK autophagy.Metformin ameliorates IL-6-induced hepatic insulin resistance via induction of orphan nuclear receptor small heterodimer partner (SHP) in mouse models.Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis.
P2860
Q24306100-FC1BC7F4-63F5-4628-937B-CC6FC93808DBQ26769682-5F306E7B-D0D8-4E93-90DA-78FFD9C8C278Q28488385-7339CE67-CDD9-4252-964D-4C55FB709BB5Q30395192-9694DD67-6CFB-42F6-BE15-7461CA675DF2Q34089730-3C05CB8A-043D-489F-AE26-F14AAD25E190Q34186447-76CB57E0-76BD-4B03-8320-39940D49C0DAQ34291303-9AE4DE5A-133C-44BA-B6F2-2B0BACD8D96DQ34451281-341F9650-DD6A-4AC6-8B31-8FE158A1DD94Q35035662-5E3CC5DA-AC0E-4788-9614-CFA2CFB26058Q35150049-22E500E1-6491-4A84-9ADF-06FFDF4FD2B7Q36072203-9A123DD7-4CD8-4884-B563-09CBBF5EB06AQ36229241-1F313CB9-171D-4F79-BDD4-C2D2252B7EF3Q36249771-6F118A2B-9EF1-4244-BEB3-D0B68E70BF65Q36465264-B2E9E9EE-0B4E-43A7-BB92-D04495C9D1D3Q37602220-329592F7-FA0B-4AAC-8CCC-0992F26D218DQ37709379-5781DB5A-3B77-40B0-96ED-23E2AFF51238Q37861626-0334573B-05CA-4335-8FFD-05CBAAF8A9D9Q38346026-60E612FE-BA83-4A96-B7C0-6C7C92973024Q38874590-1EB4F6F5-758E-4BE2-A381-61F96313A90FQ39022770-E9532323-A1CD-4E67-9C89-90F4694466AAQ39101221-846EC5CE-CADD-48FD-947B-6242787857D9Q39532126-4F20A622-ED0A-49FB-97F3-5365891BF8BAQ42000401-242DCE1F-7C34-493E-B6F4-CD3E7167112CQ42040355-B2BFF21B-5924-4220-9B1C-4ED91F4AFECFQ42702473-0746D0F8-D3BF-483A-B688-6A65DB5D7C11Q48139334-30C28DB0-4E70-43BF-9EC1-A43C6038D7F1Q51541906-0E81EAC3-209A-467E-BEF5-0A735697BA5EQ52582202-F543E575-4F20-4A4E-88EB-52A57A8D2BD2
P2860
Fenofibrate differentially regulates plasminogen activator inhibitor-1 gene expression via adenosine monophosphate-activated protein kinase-dependent induction of orphan nuclear receptor small heterodimer partner
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Fenofibrate differentially reg ...... ptor small heterodimer partner
@en
Fenofibrate differentially reg ...... tor small heterodimer partner.
@nl
type
label
Fenofibrate differentially reg ...... ptor small heterodimer partner
@en
Fenofibrate differentially reg ...... tor small heterodimer partner.
@nl
prefLabel
Fenofibrate differentially reg ...... ptor small heterodimer partner
@en
Fenofibrate differentially reg ...... tor small heterodimer partner.
@nl
P2093
P2860
P356
P1433
P1476
Fenofibrate differentially reg ...... ptor small heterodimer partner
@en
P2093
Chul Ho Lee
Dipanjan Chanda
Don-Kyu Kim
Gi Ryang Kweon
Goo-Taeg Oh
Hueng-Sik Choi
In-Kyu Lee
Ji-Hoon Park
Jung Hwan Hwang
Jung-Ran Noh
P2860
P304
P356
10.1002/HEP.23049
P407
P577
2009-09-01T00:00:00Z